What's happening
This bill expands Medicaid coverage for ovulation-enhancing drug treatments to all patients, not just women, in New York.
Why it matters
Expands reproductive healthcare access. By replacing "women" with "patients," this bill ensures that Medicaid coverage for ovulation-enhancing drugs is available to all individuals undergoing fertility treatments, including transgender men and nonbinary people who may need these services.
Addresses healthcare equity. The change helps eliminate gender-based barriers in New York's Medicaid policy, aligning with broader efforts to provide inclusive and non-discriminatory healthcare.
Maintains comprehensive fertility support. Coverage remains for essential related services—such as office visits, ultrasounds, blood testing, and specific fertility procedures—ensuring patients get complete care during ovulation treatment, not just medication.
Continued state commitment if federal funds lapse. If federal financial support drops below 90% for these services, New York will use state funds for a grant program, demonstrating a commitment to maintaining access even if federal Medicaid policy changes.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Cover Infertility Drug Treatments
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 34
1 Co-sponsor
History
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Cover Infertility Drug Treatments
In Assembly Committee · Ways And Means · Sponsor Amy Paulin
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
9158
IN SENATE
May 1, 2024
Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the social services law, in relation to medical assistance for patients in the process of oral or injectable ovulation enhancing drugs
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph (ee) of subdivision 2 of section 365-a of the social services law, as added by section 4 of part S of chapter 57 of the laws of 2017, is amended to read as follows:
(ee) Medical assistance shall include the coverage of a set of services to ensure improved outcomes of [women] patients who are in the process of oral or injectable ovulation enhancing drugs, limited to the provision of such treatment, office visits, hysterosalpingogram services, pelvic ultrasounds, and blood testing; services shall be limited to those necessary to monitor such treatment. In the event that ninety percent federal financial participation for such services is not available, the state share of appropriations related to these services shall be used for a grant program intended to accomplish the purpose of this section.
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD15045-01-4
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the social services law, in relation to medical assist- ance for patients in the process of oral or injectable ovulation enhanc- ing drugs
Purpose or general idea of bill
To require Medicaid coverage of oral and injectable forms of ovulation enhancing drugs.
Summary of provisions
Section 1 adds "oral or injectable" to paragraph (se) of section 365-a of the social services law to require Medicaid coverage of oral or injectable ovulation enhancing drugs.
Section 2 provides the effective date.
Justification
While some ovulation enhancing drugs used for fertility treatments are currently covered by Medicaid, the more effective injectable drugs, which provide better outcomes for patients, are currently not covered. This imbalance of coverage has led to individuals on Medicaid not being able to access the full spectrum of fertility treatments currently available to patients with commercial insurance, including state employ- ees.
This bill will require Medicaid coverage to include oral or injectable ovulation enhancing drugs. While in New York, Medicaid includes coverage of some oral ovulation enhancing drugs, injectables are not covered. This lack of coverage presents an immense barrier to those who want to start a family, but do not have access to the drugs that could help. By requiring Medicaid coverage of oral and injectable ovulation enhancing drugs, we allow individuals and couples struggling with fertility issues to access the most effective treatments.
Prior legislative history
New Bill.
Fiscal implications for state and local governments
None.
Effective date
This act shall take effect on the 90th day after it shall become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.